166 related articles for article (PubMed ID: 2202093)
21. Antiplatelet therapy in the prevention of stroke.
Easton JD
Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
[TBL] [Abstract][Full Text] [Related]
22. [Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
Scheen AJ
Rev Med Liege; 2000 Oct; 55(10):957-9. PubMed ID: 11244807
[TBL] [Abstract][Full Text] [Related]
23. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Rosendaal FR; Algra A
J Neurol Sci; 1997 Sep; 150(1):85, 87. PubMed ID: 9260863
[No Abstract] [Full Text] [Related]
24. Secondary prevention of myocardial infarction in the first European Stroke Prevention Study.
Lowenthal A
Thromb Res Suppl; 1990; 12():59-63. PubMed ID: 2082489
[TBL] [Abstract][Full Text] [Related]
25. Short-term outcome of medically treated patients with transient ischemic attacks, reversible ischemic neurologic deficits and strokes with minimum residuum.
Calandre L; Molina JA
Eur Neurol; 1985; 24(4):281-5. PubMed ID: 2408892
[TBL] [Abstract][Full Text] [Related]
26. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
27. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials.
Li X; Zhou G; Zhou X; Zhou S
J Neurol Sci; 2013 Sep; 332(1-2):92-6. PubMed ID: 23871093
[TBL] [Abstract][Full Text] [Related]
29. Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
Stachenko SJ; Bravo G; Côté R; Boucher J; Battista RN
Fam Pract Res J; 1991 Jun; 11(2):179-91. PubMed ID: 1829313
[TBL] [Abstract][Full Text] [Related]
30. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC; Sacco R; Yusuf S; ;
Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
[TBL] [Abstract][Full Text] [Related]
31. [2nd European study on secondary prevention of stroke (ESPS 2). Respective roles of acetylsalicylic acid, dipyridamole and their combination].
Franck G
Rev Med Liege; 1995 Nov; 50(11):491. PubMed ID: 8532998
[No Abstract] [Full Text] [Related]
32. Transient ischemic attacks. Strategies for minimizing stroke risk.
Furlan AJ
Postgrad Med; 1984 May; 75(6):183-9. PubMed ID: 6718281
[TBL] [Abstract][Full Text] [Related]
33. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
35. Secondary prevention of stroke: does dipyridamole add to aspirin?
Lowenthal A; Buyse M
Acta Neurol Belg; 1994; 94(1):24-34. PubMed ID: 8140884
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
37. [Large trials in the secondary prevention of stroke].
Gensini GF; Simone I; Pantoni L; Inzitari D
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():102S-109S. PubMed ID: 9004808
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and antiplatelet therapy in TIA and stroke patients.
Puranen J; Laakso M; Riekkinen P; Sivenius J
J Neurol Sci; 1998 Feb; 154(2):200-4. PubMed ID: 9562311
[TBL] [Abstract][Full Text] [Related]
39. Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks.
Eriksson SE
Acta Neurol Scand; 1985 Jun; 71(6):485-93. PubMed ID: 4024860
[TBL] [Abstract][Full Text] [Related]
40. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
Lutsep HL
J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
